To investigate whether decreased YAP1 levels would cause AD-like pathological damage and behavioral changes in vivo, we conducted bilateral AAV injections to selectively downregulate YAP1 within the CA3 region of the hippocampus in 2-month-old C57BL/6J mice. The gene discussed is YAP1; the disease is Alzheimer disease.